GC Biopharma USA, Inc. is a leading biopharmaceutical company specializing in the development, manufacturing, and commercialization of plasma-derived therapies and vaccines. The company generates revenue through the sale of its innovative medical products, which are essential in treating rare and chronic diseases. Originally founded as a subsidiary of GC Biopharma in South Korea, it has expanded its footprint in the U.S. market to enhance its global reach. Key historical milestones include the launch of groundbreaking treatments and strategic partnerships to advance healthcare solutions.